1) Acute exacerbation of chronic obstructive pulmonary
慢性阻塞性肺病加重期
2) Acute exacerbation of chronic obstructive pulmonary disease
慢性阻塞性肺疾病急性加重期
1.
Clinical curative effect of lung lavage by bronchoscopy in treatment with acute exacerbation of chronic obstructive pulmonary disease and its impact on pulmonary function and blood gas
经纤维支气管镜肺灌洗治疗慢性阻塞性肺疾病急性加重期的临床疗效及对肺功能和血气的影响
2.
Objectives: To explore the mechanism of Tan-Re-Qing with "clearing heat and resolving phlegm" in treatment of acute exacerbation of chronic obstructive pulmonary disease by improving airway inflammation and airway mucus hypersecretion.
目的以方代法，观察在常规西医基础治疗上，痰热清注射液治疗慢性阻塞性肺疾病急性加重期(acute exacerbation of chronic obstructive pulmonary disease，COPD)(痰热阻肺证)患者的临床疗效，同时以气道炎症、气道粘液高分泌作为切入点，客观分析和评价“清热化痰”法在治疗AECOPD中的应用价值，为该法的推广应用提供科学依据。
3.
Objective: This pape, based on clinical observation, researched the therapeutic effect of a therapy, which was the combination of acupuncture and traditional Chinese medicine, to cure Acute Exacerbation of Chronic Obstructive Pulmonary Disease and its effect on pulmonary function.
目的:通过临床观察,研究针药并治对慢性阻塞性肺疾病急性加重期(AcuteExacerbation of Chronic Obstructive Pulmonary Disease,AECOPD)临床疗效及肺功能的影响。
3) Acute Exacerbation Chronic obstructive pulmonary disease (AECOPD)
慢性阻塞性肺疾病急性加重期(AECOPD)
4) AECOPD
慢性阻塞性肺病急性加重期
1.
Objective :To investigate the changes of SAA、CRP levels and their relationship with the severity ,clinical outcomes in AECOPD required hospitalization.
目的观察慢性阻塞性肺病急性加重期(Acute exacerbations of COPD ,AECOPD)患者的血清淀粉样蛋白A(Serum amyloid A,SAA)、C-反应蛋白(C-reactive protein,CRP)水平变化以及其与AECOPD严重程度、临床预后之间的关系。
2.
Objective To investigate the bacterial flora and antimicrobial sensitivity in sputum from patients with acute exacerbations of chronic obstructive pulmonary disease(AECOPD)in order to recommend the best empirical treatment for these patients.
目的探讨老年慢性阻塞性肺病急性加重期(AECOPD)呼吸道病原菌群的分布及分析药敏试验结果。
3.
Methods Total 56 cases of AECOPD were selected, SAA and CRP was determined respectively on the time of admission ,resolution of AECOPD and stable period, also obtained in volunteers.
目的观察慢性阻塞性肺病急性加重期(AECOPD)患者的血清淀粉样蛋白A(SAA)、C反应蛋白(CRP)水平变化以及临床意义。
5) AECOPD
慢性阻塞性肺疾病急性加重期
1.
The clinical course of COPD is divided into exacerbation stage and stable stage, exacerbation is the most leading cause of mortality, therefore, we must pay more attention to diagnosis and treatment of COPD, and particularly AECOPD should be placed in the most important position.
本文选取44例慢性阻塞性肺疾病急性加重期(AECOPD)(肺功能Ⅱ和Ⅲ级)的住院患者,以及20例健康志愿者为研究对象。
2.
Objective:To evaluate the efficacy and safety of nebulized budesonide(NB) and intravenous methylprednisolone(IVM) on acute exacerbations of chronic obstructive pulmonary disease(AECOPD).
目的:比较雾化吸入布地奈德与静滴甲泼尼松龙在慢性阻塞性肺疾病急性加重期(AECOPD)的疗效及安全性。
6) Chronic obstructive pulmonary disease at acute exacerbation phase
慢性阻塞型肺病急性加重期
补充资料：肝外阻塞性胆汁性肝硬化
肝外阻塞性胆汁性肝硬化
又称"继发性胆汁性肝硬化。*胆汁性肝硬化的一个类型，继发于肝外胆管阻塞而引起的肝硬化。主要由总胆管结石、手术后胆管狭管、胰头癌、先天性胆管闭锁或缺如等原因所造成。在梗阻上端的胆道由下而上地逐渐扩大迂曲，胆汁淤积，肝内小胆管扩大而破裂，使肝血管受压，胆汁外渗，肝细胞发生缺血、坏死，纤维组织增生，最后形成肝硬化。临床表现为黄疸、肝脾肿大，皮肤粘膜出血倾向，血胆固醇下降等，晚期表现同*肝硬化。解除肝外阻塞原因，本病有治愈的可能性。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条